Round 1 Winners!
Proof of Usefulness Report

Likemind

Analysis completed on 3/23/2026

-88
Proof of Usefulness Score
Lab Mode

The submission exhibits severe red flags, heavily indicating a fake or spam application. While the description is lifted from a legitimate biomedical imaging company, the applicant's details ('BlazeFang') and absurd claims ('most people have used my product', 'all time marketcap: 2500000', reach 'everyone') show zero verifiable traction and drastically undermine credibility, resulting in a negative score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50
Audience Reach Impact-50
Technical Innovation+15
Evidence Of Traction-75
Market Timing Relevance+5
Functional Completeness-25
Subtotal-80
Usefulness Multiplierx1.1
Final Score-88

Project Details

Project URL
Description
LikeMinds is a Boston-based dopamine transporter (DAT) imaging company. The LikeMinds team previously developed Neupro®, the world’s first transdermal movement disorder drug for Parkinson’s and Restless Legs Syndrome. LikeMinds has assembled a globally recognized board of directors, board of advisors and strategic collaborators. Utilizing proprietary DAT imaging and machine learning, LikeMinds will revolutionize the way doctors and pharmaceutical companies predict, diagnose, monitor and treat dopamine-related diseases. Someday, doctors will detect dopamine-mediated diseases years before the first symptoms, thereby enabling early medical intervention. Our mission is to help make someday happen sooner.

Algorithm Insights

Market Position
Early stage requiring focused development
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline